Encyclopedia of Signaling Molecules

Living Edition
| Editors: Sangdun Choi

FGF (Fibroblast Growth Factor)

  • Masaru Katoh
Living reference work entry
DOI: https://doi.org/10.1007/978-1-4614-6438-9_313-1

Synonyms

Historical Background

The founding members of the fibroblast growth factor (FGF) family are FGF1 (acidic FGF or aFGF) and FGF2 (basic FGF or bFGF), which were initially purified from bovine brain and pituitary gland as mitogens for fibroblasts. Mouse Fgf3 (int-2) was cloned and characterized as a proto-oncogene that is aberrantly upregulated in mammary tumors due to the proviral integration of mouse mammary tumor virus (MMTV). Human FGF4 (K-FGF) was cloned and characterized as a proto-oncogene following the transfection of genomic DNA from Kaposi sarcoma into mouse NIH 3T3 cells. In addition, 18 FGFs have been cloned and characterized based on their homology to FGF1 ~ FGF4 (Reviewed in Katoh 2002). Because the CCND1 – ORAOV1 – FGF19 – FGF4 – FGF3locus at human...

Keywords

Fibroblast Growth Factor Mouse Mammary Tumor Virus Fibroblast Growth Factor Signaling FGFR Gene Acidic Fibroblast Growth Factor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

References

  1. ADHR Consortium. Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nat Genet. 2000;26:345–8.CrossRefGoogle Scholar
  2. Barak H, Huh SH, Chen S, Jeanpierre C, Martinovic J, Parisot M, et al. FGF9 and FGF20 maintain the stemness of nephron progenitors in mice and man. Dev Cell. 2012;22:1191–207.CrossRefPubMedPubMedCentralGoogle Scholar
  3. Carpenter TO, Imel EA, Ruppe MD, Weber TJ, Klausner MA, Wooddell MM, et al. Randomized trial of the anti-FGF23 antibody KRN23 in X-linked hypophosphatemia. J Clin Invest. 2014;124:1587–97.CrossRefPubMedPubMedCentralGoogle Scholar
  4. Carter EP, Fearon AE, Grose RP. Careless talk costs lives: fibroblast growth factor receptor signalling and the consequences of pathway malfunction. Trends Cell Biol. 2015;25:221–33.CrossRefPubMedGoogle Scholar
  5. Dalski A, Atici J, Kreuz FR, Hellenbroich Y, Schwinger E, Zühlke C. Mutation analysis in the fibroblast growth factor 14 gene: frameshift mutation and polymorphisms in patients with inherited ataxias. Eur J Hum Genet. 2005;13:118–20.CrossRefPubMedGoogle Scholar
  6. Degirolamo C, Sabba C, Moschetta A. Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23. Nat Rev Drug Discov. 2016;15:51–69.CrossRefPubMedGoogle Scholar
  7. El Agha E, Kosanovic D, Schermuly RT, Bellusci S. Role of fibroblast growth factors in organ regeneration and repair. Semin Cell Dev Biol. 2016;53:76–84.CrossRefPubMedGoogle Scholar
  8. Folsom LJ, Imel EA. Hyperphosphatemic familial tumoral calcinosis: genetic models of deficient FGF23 action. Curr Osteoporos Rep. 2015;13:78–87.CrossRefPubMedGoogle Scholar
  9. Higgins CA, Petukhova L, Harel S, Ho YY, Drill E, Shapiro L, et al. FGF5 is a crucial regulator of hair length in humans. Proc Natl Acad Sci USA. 2014;111:10648–53.CrossRefPubMedPubMedCentralGoogle Scholar
  10. Jamsheer A, Zemojtel T, Kolanczyk M, Stricker S, Hecht J, Krawitz P, et al. Whole exome sequencing identifies FGF16 nonsense mutations as the cause of X-linked recessive metacarpal 4/5 fusion. J Med Genet. 2013;50:579–84.CrossRefPubMedGoogle Scholar
  11. Katoh M. WNT and FGF gene clusters. Int J Oncol. 2002;21:1269–73.PubMedGoogle Scholar
  12. Katoh M. WNT signaling in stem cell biology and regenerative medicine. Curr Drug Targets. 2008;9:565–70.CrossRefPubMedGoogle Scholar
  13. Katoh M. Therapeutics targeting FGF signaling network in human diseases. Prends Pharmacol Sci. 2016;37:1081–96.Google Scholar
  14. Katoh M, Katoh M. Evolutionary conservation of CCND1 – ORAOV1 – FGF19 – FGF4 locus from zebrafish to human. Int J Mol Med. 2003;12:45–50.PubMedGoogle Scholar
  15. Katoh M, Nakagama H. FGF receptors: cancer biology and therapeutics. Med Res Rev. 2014;34:280–300.CrossRefPubMedGoogle Scholar
  16. Kirikoshi H, Sagara N, Saitoh T, Sekihara H, Shiokawa K, Katoh M. Molecular cloning and characterization of human FGF-20 on chromosome 8p21.3-p22. Biochem Biophys Res Commun. 2000;274:337–43.CrossRefPubMedGoogle Scholar
  17. Milunsky JM, Zhao G, Maher TA, Colby R, Everman DB. LADD syndrome is caused by FGF10 mutations. Clin Genet. 2006;69:349–54.CrossRefPubMedGoogle Scholar
  18. Miraoui H, Dwyer AA, Sykiotis GP, Plummer L, Chung W, Feng B, et al. Mutations in FGF17, IL17RD, DUSP6, SPRY4, and FLRT3 are identified in individuals with congenital hypogonadotropic hypogonadism. Am J Hum Genet. 2013;92:725–43.CrossRefPubMedPubMedCentralGoogle Scholar
  19. Ornitz DM, Itoh N. The fibroblast growth factor signaling pathway. Wiley Interdiscip Rev Dev Biol. 2015;4:215–66. .xCrossRefPubMedPubMedCentralGoogle Scholar
  20. Tekin M, Oztürkmen Akay H, Fitoz S, Birnbaum S, Cengiz FB, et al. Homozygous FGF3 mutations result in congenital deafness with inner ear agenesis, microtia, and microdontia. Clin Genet. 2008;73:554–65.CrossRefPubMedGoogle Scholar
  21. Tian H, Zhao Y, Chen N, Wu M, Gong W, Zheng J, et al. High production in E. coli of biologically active recombinant human fibroblast growth factor 20 and its neuroprotective effects. Appl Microbiol Biotechnol. 2016;100:3023–34.CrossRefPubMedGoogle Scholar
  22. Trarbach EB, Abreu AP, Silveira LF, Garmes HM, Baptista MT, Teles MG, et al. Nonsense mutations in FGF8 gene causing different degrees of human gonadotropin-releasing deficiency. J Clin Endocrinol Metab. 2010;95:3491–6.CrossRefPubMedPubMedCentralGoogle Scholar
  23. Wang G, van der Walt JM, Mayhew G, Li YJ, Züchner S, Scott WK, et al. Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of a-synuclein. Am J Hum Genet. 2008;82:283–9.CrossRefPubMedPubMedCentralGoogle Scholar
  24. Zhang J, Li Y. Therapeutic uses of FGFs. Semin Cell Dev Biol. 2016;53:144–54.CrossRefPubMedGoogle Scholar
  25. Zhao X, Wu Y, Zhao C, Feng M. Association between FGF20 rs12720208 gene polymorphism and Parkinson’s disease: a meta-analysis. Neurol Sci. 2016;37:1119–26.CrossRefPubMedGoogle Scholar
  26. Zhu R, Zhu Y, Liu X, He Z. Fibroblast growth factor 20 (FGF20) gene polymorphism and risk of Parkinson’s disease: a meta-analysis. Neurol Sci. 2014;35:1889–94.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media LLC 2016

Authors and Affiliations

  1. 1.Department of Omics NetworkNational Cancer CenterTokyoJapan